Literature DB >> 30129184

Circ_0056618 and CXCR4 act as competing endogenous in gastric cancer by regulating miR-206.

Hongbo Li1, Guoliang Yao1, Bing Feng1, Xueliang Lu2, Yonggang Fan1.   

Abstract

Circular RNAs (circRNAs) have proved to play an important role in gastric cancer. In this study, we found that circ_0056618 took part in gastric cancer cell proliferation and survival. The real-time polymerase chain reaction result showed that circ_0056618 was overexpressed in tumor tissues or cells compared with adjacent normal tissues or normal cells and had a negative relationship to gastric cancer patients' survival time. Meanwhile, the inhibition of circ_0056618 suppressed the proliferation and metastasis of gastric cancer cells. Further bioinformatical analysis indicated that circ_0056618 sponged miR-206 to regulate CXCR4 according to the prediction of TargetScan and miRanda. Dual-luciferase reporter assay and Western blot analysis revealed the underlying relationship of circ_0056618, miR-206, and CXCR4. Hence, circ_0056618 negatively regulated miR-206 expression promoting CXCR4 expression. Altogether, circ_0056618 is a potential gastric cancer prognostic marker, as well as a potential therapeutic target to inhibit gastric cancer metastasis.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  CXCR4; circ_0056618; gastric cancer; miR-206

Mesh:

Substances:

Year:  2018        PMID: 30129184     DOI: 10.1002/jcb.27271

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  10 in total

Review 1.  The emerging roles of circular RNAs in vessel co-option and vasculogenic mimicry: clinical insights for anti-angiogenic therapy in cancers.

Authors:  Ying Shao; Bingjian Lu
Journal:  Cancer Metastasis Rev       Date:  2021-10-18       Impact factor: 9.264

2.  Circ-GSK3B up-regulates GSK3B to suppress the progression of lung adenocarcinoma.

Authors:  Ming-Chuang Zhu; Yan-Hong Zhang; Peng Xiong; Xiao-Wu Fan; Guo-Liang Li; Min Zhu
Journal:  Cancer Gene Ther       Date:  2022-07-11       Impact factor: 5.854

3.  CircRAD18 Accelerates the Progression of Acute Myeloid Leukemia by Modulation of miR-206/PRKACB Axis.

Authors:  Yanyan Wang; Te Guo; Quan Liu; Xianfei Xie
Journal:  Cancer Manag Res       Date:  2020-10-30       Impact factor: 3.989

Review 4.  The crosstalk between circular RNAs and the tumor microenvironment in cancer metastasis.

Authors:  Ying Shao; Bingjian Lu
Journal:  Cancer Cell Int       Date:  2020-09-11       Impact factor: 5.722

5.  Hsa_circ_0023642 promotes proliferation, invasion, and migration of gastric cancer by sponging microRNA-223.

Authors:  Yi Zhang; Lei Xia; Jing Wu; Xinyu Xu; Gang Li
Journal:  J Clin Lab Anal       Date:  2020-06-19       Impact factor: 2.352

6.  circPTEN suppresses colorectal cancer progression through regulating PTEN/AKT pathway.

Authors:  Chen Li; Xu Li
Journal:  Mol Ther Nucleic Acids       Date:  2021-05-29       Impact factor: 10.183

7.  circ_AKT3 knockdown suppresses cisplatin resistance in gastric cancer.

Authors:  Wenting Shi; Fang Wang
Journal:  Open Med (Wars)       Date:  2022-02-14

Review 8.  Circular RNAs in gastrointestinal cancer: Current knowledge, biomarkers and targeted therapy (Review).

Authors:  Xiaorui Zhao; Yue Wang; Qiongfang Yu; Pei Yu; Qiaoyu Zheng; Xue Yang; Dian Gao
Journal:  Int J Mol Med       Date:  2020-09-16       Impact factor: 4.101

9.  The prognostic value of circRNAs for gastric cancer: A systematic review and meta-analysis.

Authors:  Hui Chen; Chengtong Liang; Xuechun Wang; Yu Liu; Zhanjun Yang; Ming Shen; Chongxu Han; Chuanli Ren
Journal:  Cancer Med       Date:  2020-10-27       Impact factor: 4.452

10.  Astragalus IV Undermines Multi-Drug Resistance and Glycolysis of MDA-MB-231/ADR Cell Line by Depressing hsa_circ_0001982-miR-206/miR-613 Axis.

Authors:  Hongchang Li; Zhihua Xia; Limin Liu; Gaofeng Pan; Junbin Ding; Jiazhe Liu; Jie Kang; Jindong Li; Daowen Jiang; Weiyan Liu
Journal:  Cancer Manag Res       Date:  2021-07-22       Impact factor: 3.989

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.